Who
Anthony S. Gibney
Officer
Company insider
Files Form 4 as: Officer, Aura Biosciences; Director, Clearside Biomedical; EVP, Chief Business Officer, IVERIC bio; EVP, Chief Business Officer, Achillion Pharmaceuticals.
In numbers
- Trades disclosed
- 39
- Buys
- 3
- Sells
- 3
- Bought
- $375K
- Sold
- $246K
- Companies
- 4
- Companies where not an officer
- 1
- First trade
- 15 Aug 2018
- Last trade
- 16 Jun 2026
- Last filed
- 16 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jun 2026filed 16 Jun 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Sold | $82K12,824 at $6.42 | filing |
| 16 Jun 2026filed 16 Jun 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Sold | $82K12,824 at $6.42 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —71,245 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —128,755 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —128,755 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —71,245 at $0.00 | filing |
| 2 Jun 2025filed 4 Jun 2025 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 2 Jun 2025filed 4 Jun 2025 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 16 May 2025filed 20 May 2025 | AURA Aura Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code P | —12,500 | filing |
| 16 May 2025filed 20 May 2025 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Bought | $245K50,000 at $4.90 | filing |
| 16 May 2025filed 20 May 2025 | AURA Aura BiosciencesBiotechnology | SEC FORM 4 Sold | $7,8231,519 at $5.15 | filing |
| 20 Jun 2024filed 21 Jun 2024 | Clearside Biomedicaloption or derivative | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 18 Apr 2024filed 19 Apr 2024 | Clearside Biomedical | SEC FORM 4 Bought | $121K93,290 at $1.30 | filing |
| 17 Apr 2024filed 19 Apr 2024 | Clearside Biomedical | SEC FORM 4 Bought | $8,3886,710 at $1.25 | filing |
| 15 Apr 2024filed 16 Apr 2024 | Clearside Biomedicaloption or derivative | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 11 Jul 2023filed 13 Jul 2023 | IVERIC biooption or derivative | SEC FORM 4 Code D | —75,000 | filing |
| 11 Jul 2023filed 13 Jul 2023 | IVERIC biooption or derivative | SEC FORM 4 Code D | —25,000 | filing |
| 11 Jul 2023filed 13 Jul 2023 | IVERIC biooption or derivative | SEC FORM 4 Code D | —56,250 | filing |
| 11 Jul 2023filed 13 Jul 2023 | IVERIC biooption or derivative | SEC FORM 4 Code D | —200,000 | filing |
| 11 Jul 2023filed 13 Jul 2023 | IVERIC biooption or derivative | SEC FORM 4 Code D | —50,000 | filing |
News
No headline names them, or the companies they trade most, lately.